Cash Flow Statement
Growth Metrics

Lifecore Biomedical, Inc. \De\ (LFCR) Gross Profit (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Gross Profit over the past 16 years, most recently at $14.0 million for Q2 2025.

  • For Q2 2025, Gross Profit fell 19.05% year-over-year to $14.0 million; the TTM value through May 2025 reached $40.3 million, down 3.71%, while the annual FY2025 figure was $40.3 million, 3.71% down from the prior year.
  • Gross Profit for Q2 2025 was $14.0 million at Lifecore Biomedical, Inc. \De\, up from $9.8 million in the prior quarter.
  • Over five years, Gross Profit peaked at $17.3 million in Q2 2024 and troughed at $2.7 million in Q3 2023.
  • A 5-year average of $9.7 million and a median of $10.2 million in 2022 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: tumbled 54.37% in 2023 and later skyrocketed 122.03% in 2024.
  • Year by year, Gross Profit stood at $11.5 million in 2021, then tumbled by 50.44% to $5.7 million in 2022, then skyrocketed by 75.33% to $10.0 million in 2023, then grew by 11.32% to $11.1 million in 2024, then rose by 26.15% to $14.0 million in 2025.
  • Business Quant data shows Gross Profit for LFCR at $14.0 million in Q2 2025, $9.8 million in Q1 2025, and $11.1 million in Q4 2024.